Did you know PBMs will negotiate prescription drug costs down by $654 over ten years.

Visit the Site

New Research

Rebates are Unrelated to Drugmakers’ Pricing Strategies

View Study

Protect The Savings:

If regulators gut PBM negations from Medicare Part D 3 Things We Know Will Happen

Visit the Site

Opioid Crisis

PCMA Highlights PBM Solutions to Address the Opioid Crisis

Visit the Site

New Research

Eliminating Drugmaker Rebates Leads to Higher Medicare Part D Premiums

View Study

PCMA Press Releases


sPCMA Business Forum 
March 11 & 12, 2019
Orlando, FL

Join us for the year’s most important specialty pharmacy business conference. The event offers invaluable networking and education for individuals and companies involved in specialty drug benefit management including specialty pharmacies, PBMs, drug manufacturers, and others.

Learn More



PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others. PBMs are projected to save employers, unions, government programs, and consumers $654 billion— up to 30 percent—on drug benefit costs over the next decade.

Stay Connected with PCMA!